stockrowUnited Therapeutics Corporation
UTHR Healthcare Drug Manufacturers Specialty & Generic
United Therapeutics Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 10.6% from fiscal 2024.
- Revenue
- +4.13%
- EPS
- −21.7%
- Free cash flow
- −63.7%
Quarter to September 2026, against a year earlier
Follow UTHR
Alert me
United Therapeutics Corporation (UTHR) Shares outstanding
United Therapeutics Corporation's shares outstanding at the end of fiscal 2025 was $47.9M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $45.3M. Over the past ten years it has ranged from $43.8M (fiscal 2019) to $51.2M (fiscal 2015); the current reading is higher than 64% of that period. United Therapeutics Corporation ranks 46th of 81 Drug Manufacturers Specialty & Generic companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $47.9M | (1.24%) |
| FY2024 | $48.5M | (2.41%) |
| FY2023 | $49.7M | 2.47% |
| FY2022 | $48.5M | 2.54% |
| FY2021 | $47.3M | 6.05% |
| FY2020 | $44.6M | 1.83% |
| FY2019 | $43.8M | (0.45%) |
| FY2018 | $44.0M | (2.00%) |
| FY2017 | $44.9M | (4.06%) |
| FY2016 | $46.8M | (8.59%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $45.3M | (1.09%) |
| Jun 2026 | $45.8M | (2.97%) |
| Mar 2026 | $47.2M | (1.46%) |
| Dec 2025 | $47.9M | 1.27% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| HLN Haleon PLC Sponsored ADR compare | $4.6B |
| TAK Takeda Pharmaceutical Co. compare | $3.2B |
| TEVA Teva Pharmaceutical Industries Ltd. compare | $1.2B |
| VTRS Viatris Inc. compare | $1.2B |
| RDY Dr. Reddy's Laboratories Ltd compare | $833.3M |
| ELAN Elanco Animal Health Incorporated compare | $505.9M |
| ZTS Zoetis Inc. compare | $417.7M |
| NBIX Neurocrine Biosciences, Inc. compare | $105.2M |
| UTHR United Therapeutics Corporation | $45.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on UTHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement